An early-phase, dose-escalation study of a hypofractionated approach to concurrent chemoradiation using an an adaptive stereotactic ablative radiotherapy (SABR) boost showed promising results in ...
A new study has identified that highly targeted and strong doses of a type of radiotherapy called stereotactic ablative radiation (SABR) could slow disease progression among a subgroup of men who have ...
Advances in radiotherapy are rapidly transforming how prostate cancer is treated, offering patients more precise, less invasive options that can fit more easily around everyday life ...
The use of either MRI-guided stereotactic ablative body radiotherapy (SABR) or CT-guided percutaneous irreversible electroporation after standard FOLFIRINOX chemotherapy did not result in any ...
Please provide your email address to receive an email when new articles are posted on . Stereotactic ablative radiotherapy appeared as effective as surgery among patients with operable early-stage non ...
Stereotactic ablative body radiotherapy (SABR) is a safe, noninvasive, and effective strategy for treating primary renal cell cancer (RCC) in patients not suited to undergo surgical resection. At 1 ...
A new study showed that stereotactic ablative radiotherapy (SABR) was as effective as surgery at providing long-term benefits to patients with operable early-stage non-small cell lung cancer (NSCLC) ...
Stereotactic ablative radiotherapy can deliver highly focused radiation to metastases (left). The ORIOLE trial showed that this can slow prostate cancer progression (right). (Courtesy: Radiat. Oncol ...
Global Incidence of Ovarian Cancer According to Histologic Subtype: A Population-Based Cancer Registry Study Local ablative therapy, such as radiotherapy or surgery, plays a key role in treatment of ...
Please provide your email address to receive an email when new articles are posted on . Surgery and stereotactic ablative radiotherapy conferred comparable 10-year survival among patients with ...
Patients with inoperable kidney cancer saw significant results in local control and cancer-specific survival with stereotactic ablative body radiotherapy. Patients with inoperable kidney cancer ...